Loading…
Pulmonx Corporation is projected to rise to $2.20 by 2027, a +35% move from its current price of $1.63. LUNG is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $1.55 | $1.63 | $1.71 | +0.04% |
| Aug 6 | $1.52 | $1.63 | $1.75 | +0.08% |
| Aug 7 | $1.50 | $1.63 | $1.78 | +0.11% |
| Aug 8 | $1.48 | $1.63 | $1.80 | +0.15% |
| Aug 9 | $1.46 | $1.63 | $1.82 | +0.19% |
| Aug 10 | $1.45 | $1.63 | $1.84 | +0.23% |
| Aug 11 | $1.44 | $1.63 | $1.86 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.44 | $1.63 | $1.86 | +0.26% |
| Week 2 | $1.37 | $1.64 | $1.97 | +0.53% |
| Week 3 | $1.31 | $1.64 | $2.05 | +0.79% |
| Week 4 | $1.27 | $1.65 | $2.13 | +1.06% |
| Week 5 | $1.24 | $1.65 | $2.20 | +1.33% |
| Week 6 | $1.21 | $1.66 | $2.27 | +1.59% |
| Week 7 | $1.18 | $1.66 | $2.33 | +1.86% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Pulmonx Corporation is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema. It offers Zephyr Endobronchial Valve and the Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
The company also offers the LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for a solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves.
Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California. It was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.
Pulmonx Corporation (LUNG) is currently priced at $1.61 with a market capitalization of $68M. It ranks 4146.
The near-term forecast for 2026 shows min $1.17, avg $1.61, max $2.16 with ROI 0% and sentiment NEUTRAL.
From 2027 onward, the forecast shows bullish sentiment with higher averages, culminating in a long-run upside as avg prices rise toward the end of the forecasting horizon (2050 avg $8.41).
A major floor 37.6% below — a decisive break under it would weaken the trend.
The nearest floor, 28.2% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 18.8% above — clearing it would confirm fresh momentum.
Key LUNG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LUNG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.39 | Buy | $1.45 | Buy |
| MA 10 | $1.32 | Buy | $1.39 | Buy |
| MA 20 | $1.39 | Buy | $1.38 | Buy |
| MA 50 | $1.42 | Buy | $1.39 | Buy |
| MA 100 | $1.40 | Buy | $1.46 | Buy |
| MA 200 | $1.61 | Buy | $1.81 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.63 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 130.00 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 13.19 | Buy |
| Bollinger %B (20,2) | 0.93 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.22 | Sell |
| Awesome (5,34) | 0.03 | Buy |
| Ultimate (7,14,28) | 77.40 | Sell |
| Momentum (10) | 0.23 | Buy |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 1.52 | Buy |
| ADX (14) | 16.55 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is BULLISH, with RSI14 at 60. The price action is currently interacting with notable moving averages: SMA50 at $1.42 and SMA200 at $1.61, placing the last price near resistance of $1.61 and above a support level of $1.17.
The 30-day range spans from a low of $1.16 to a high of $2.24, indicating room for movement within a broad range in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.17 | $1.63 | $2.17 | 0% | Neutral | |
| $1.63 | $2.20 | $3.19 | +35% | Bullish | |
| $1.55 | $2.21 | $3.42 | +36% | Bullish | |
| $1.48 | $2.21 | $3.57 | +36% | Bullish | |
| $1.39 | $2.16 | $3.63 | +32% | Bullish | |
| $1.39 | $2.25 | $3.90 | +38% | Bullish | |
| $1.45 | $2.44 | $4.36 | +50% | Bullish | |
| $1.67 | $2.90 | $5.33 | +78% | Bullish | |
| $2.05 | $3.68 | $6.92 | +126% | Bullish | |
| $2.04 | $3.79 | $7.28 | +133% | Bullish | |
| $2.44 | $5.33 | $11.20 | +227% | Bullish | |
| $3.89 | $8.65 | $19.89 | +431% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.17 | $1.63 | $1.93 | +0.00% |
| September 2026 | $1.32 | $1.60 | $2.01 | -2.14% |
| October 2026 | $1.38 | $1.69 | $2.16 | +5.76% |
| November 2026 | $1.35 | $1.67 | $2.17 | -1.21% |
| December 2026 | $1.32 | $1.65 | $2.17 | -1.27% |
Click any year to see its month-by-month LUNG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LUNG could reach as high as $2.17, with a base case around $1.63 and support toward $1.17 — roughly 0% from $1.63. A consolidation phase looks the most probable path here.
Expect LUNG to range from $1.63 to $3.19 through 2027. The $2.20 average target implies a +35% move from current prices. That is up +35% on the projected 2026 average. Momentum favours further upside here.
The LUNG price prediction for 2028 points to an average of $2.21 (low $1.55, high $3.42) — a potential gain of +36% on today's $1.63. Buyers look set to stay in control over this stretch.
In 2029, LUNG is projected to trade between $1.48 and $3.57, averaging $2.21 — a potential gain of +36% from today's $1.63. That is 0% versus the projected 2028 average. Momentum favours further upside here.
Pulmonx Corporation's 2030 outlook centres on $2.16, within a $1.39 to $3.63 range. That is -2% versus the projected 2029 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, LUNG could reach as high as $3.90, with a base case around $2.25 and support toward $1.39 — roughly +38% from $1.63. Momentum favours further upside here.
Expect LUNG to range from $1.45 to $4.36 through 2032. The $2.44 average target implies a +50% move from current prices. That is up +8% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The LUNG price prediction for 2033 points to an average of $2.90 (low $1.67, high $5.33) — a potential gain of +78% on today's $1.63. Momentum favours further upside here.
In 2034, LUNG is projected to trade between $2.05 and $6.92, averaging $3.68 — a potential gain of +126% from today's $1.63. That is up +27% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Pulmonx Corporation's 2035 outlook centres on $3.79, within a $2.04 to $7.28 range. That is up +3% on the projected 2034 average. That marks a +133% change versus current levels. Momentum favours further upside here.
By 2040, LUNG could reach as high as $11.20, with a base case around $5.33 and support toward $2.44 — roughly +227% from $1.63. Buyers look set to stay in control over this stretch.
Expect LUNG to range from $3.89 to $19.89 through 2050. The $8.65 average target implies a +431% move from current prices. That is up +62% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LUNG today (≈ 613.496933 LUNG) could be worth
$5,306.15
+$4,306.15 (+431%) by 2050 · US Dollar
Based on the average projected LUNG price of $8.65 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LUNGwould be worth at today's price.
$1,000 invested in LUNG on Jul 31, 2025 (≈ 543.478251 LUNG) would be worth
$885.87
-$114.13 (-11.4%) today · 0.89× · US Dollar
Based on a LUNG entry price of $1.84 vs. today's $1.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.17 | $1,393.16 | +39.3% |
| 1 month ago | $1.47 | $1,108.84 | +10.9% |
| 3 months ago | $1.35 | $1,207.41 | +20.7% |
| 6 months ago | $1.63 | $1,000 | +0.0% |
| 1 year ago | $1.84 | $885.87 | -11.4% |
| All time (5.0y) ago | $42.28 | $38.55 | -96.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LUNG forecast.
Our base-case forecast reaches $3.30 around 2034.
Implied market cap at $3.30: $139.38M
The multi-year forecast projects bullish sentiment for most of the horizon, beginning with 2026 where the min is $1.17, avg $1.61, max $2.16 and ROI 0%. In 2027, the avg price rises to $2.19 with a max of $3.21 and ROI of 36.1%, signaling meaningful upside.
By 2030 the forecast shows avg $2.13, min $1.35, max $3.62 with ROI 32.5% and sentiment BULLISH, continuing the upward trajectory. The path extends to 2040 with avg $5.16, min $2.32, max $11.00 and ROI 220.8% (sentiment BULLISH), and to 2050 with avg $8.41, min $3.79, max $19.35 and ROI 422.6% (sentiment BULLISH).
These are estimates, not guarantees, and are subject to market and sector uncertainties.
Tap a question to reveal the answer.
Average price in 2030 is $2.13, with a min of $1.35 and a max of $3.62; ROI 32.5%; sentiment BULLISH.
The 2026 forecast is NEUTRAL with min $1.17, avg $1.61, max $2.16 and ROI 0%. From 2027 onward, the outlook is BULLISH with higher averages and positive ROI, culminating in a long-run bullish stance.
Yes. The forecast shows max prices above $3 in several years: 2027 max $3.21, 2028 max $3.38, 2029 max $3.55, and 2030 max $3.62.
Average price is $5.16, with min $2.32 and max $11.00; ROI 220.8%; sentiment BULLISH.
Average price is $8.41, with min $3.79 and max $19.35; ROI 422.6%; sentiment BULLISH.
Pulmonx Corporation Community Discussion
0Share your Pulmonx Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.